Literature DB >> 23229822

[Muir-Torre syndrome with previously undescribed frameshift mutation in the MSH2 gene].

B Gilly1, A Unholzer, G Strobl-Wildemann, C Haas, H Starz, J Welzel.   

Abstract

Muir-Torre syndrome (MTS) is a rare phenotypic variant of hereditary non-polyposis colorectal carcinoma (HNPCC, Lynch syndrome), in which patients, in addition to visceral carcinomas, develop skin tumors. Multiple keratoacanthomas and basal cell carcinomas with sebocytic differentiation are characteristic as well as multiple benign and malignant tumors of the sebaceous glands, such as sebaceous adenoma, sebaceous epithelioma (sebaceoma) and sebaceous carcinoma. Particularly Cystic tumors of the sebaceous glands are especially suggestive of MTS. In genetically predisposed persons, cutaneous and visceral tumors are diagnosed at an average age of 53 years. Here we present an interesting case of a 65-year-old man in whom molecular genetic tests revealed a novel mutation in the MSH2 gene, leading to a frame shift within the gene.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23229822     DOI: 10.1007/s00105-012-2503-z

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  18 in total

1.  Isotretinoin for sebaceous skin lesions in Muir-Torre syndrome: a case report.

Authors:  J A Marcusson; B Bjarnason; A M Ros
Journal:  Acta Derm Venereol       Date:  1998-11       Impact factor: 4.437

2.  Muir-Torre syndrome. Histologic spectrum of sebaceous proliferations.

Authors:  W H Burgdorf; J Pitha; A Fahmy
Journal:  Am J Dermatopathol       Date:  1986-06       Impact factor: 1.533

3.  Cystic sebaceous tumors as marker lesions for the Muir-Torre syndrome: a histopathologic and molecular genetic study.

Authors:  A Rütten; W Burgdorf; H Hügel; H Kutzner; H R Hosseiny-Malayeri; W Friedl; P Propping; R Kruse
Journal:  Am J Dermatopathol       Date:  1999-10       Impact factor: 1.533

4.  Multiple primary carcinomata of the colon, duodenum, and larynx associated with kerato-acanthomata of the face.

Authors:  E G Muir; A J Bell; K A Barlow
Journal:  Br J Surg       Date:  1967-03       Impact factor: 6.939

5.  New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.

Authors:  H F Vasen; P Watson; J P Mecklin; H T Lynch
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

6.  Muir-Torre syndrome - treatment with isotretinoin and interferon alpha-2a can prevent tumour development.

Authors:  T Graefe; U Wollina; H Schulz; W Burgdorf
Journal:  Dermatology       Date:  2000       Impact factor: 5.366

Review 7.  Association of sebaceous gland tumors and internal malignancy: the Muir-Torre syndrome.

Authors:  P R Cohen; S R Kohn; R Kurzrock
Journal:  Am J Med       Date:  1991-05       Impact factor: 4.965

8.  Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.

Authors:  Asad Umar; C Richard Boland; Jonathan P Terdiman; Sapna Syngal; Albert de la Chapelle; Josef Rüschoff; Richard Fishel; Noralane M Lindor; Lawrence J Burgart; Richard Hamelin; Stanley R Hamilton; Robert A Hiatt; Jeremy Jass; Annika Lindblom; Henry T Lynch; Païvi Peltomaki; Scott D Ramsey; Miguel A Rodriguez-Bigas; Hans F A Vasen; Ernest T Hawk; J Carl Barrett; Andrew N Freedman; Sudhir Srivastava
Journal:  J Natl Cancer Inst       Date:  2004-02-18       Impact factor: 13.506

9.  Oral isotretinoin therapy for familial Muir-Torre syndrome.

Authors:  R L Spielvogel; R L DeVillez; L C Roberts
Journal:  J Am Acad Dermatol       Date:  1985-03       Impact factor: 11.527

10.  Mismatch repair proteins expression and microsatellite instability in skin lesions with sebaceous differentiation: a study in different clinical subgroups with and without extracutaneous cancer.

Authors:  Anna Maria Cesinaro; Alessandro Ubiali; Pamela Sighinolfi; Gian Paolo Trentini; Francesca Gentili; Fabio Facchetti
Journal:  Am J Dermatopathol       Date:  2007-08       Impact factor: 1.533

View more
  1 in total

1.  [Colorectal cancer and associated sebaceous gland carcinoma - a syndrome?]

Authors:  J Harms; B Kunzmann; T Reineke-Plaass; H H Kreipe; A Reinecke-Lüthge; R Czymek; T Jungbluth
Journal:  Chirurg       Date:  2017-08       Impact factor: 0.955

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.